|
CTD Dossier Requirements:Focus on EU Module 1 and Quality Module 3 |
|
|
More details |
|
CTD Dossier Requirements:Focus on EU Module 1 and Quality Module 3 |
|
|
More details |
|
Regulatory Affairs Part 1: The IND Phase and Part II: The NDA Phase |
|
|
More details |
|
European Regulatory Affairs |
|
|
More details |
|
5th European Forum for Qualified Person for Pharmacovigilance (QPPV) |
|
|
More details |
|
3rd Annual AsiaTides - Oligonucleotide and Peptide® |
|
|
More details |
|
ChinaBio® Partnering Forum 2011 |
|
|
More details |
|
BIO-Europe Spring® 2011 — 5th International Partnering Conference |
|
|
More details |
|
EuroMedtech™ 2011 - Date: May 16–17, 2011 |
|
|
More details |
|
DIA/FDA Quantitative Structure-activity Relationship (Q)SAR Approaches to Assessing Genotoxic Impurities in Pharmaceuticals |
|
|
More details |